Literature DB >> 9663193

Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique.

T S Tsang1, W K Freeman, L J Sinak, J B Seward.   

Abstract

Percutaneous pericardiocentesis was introduced during the 19th century and became a preferred technique for the management of pericardial effusion by the early 20th century. Until the era of two-dimensional echocardiographically guided pericardiocentesis, however, the procedure was essentially "blind," and serious complications were comparatively common, an outcome that resulted in an increased preference for surgical solutions. Because two-dimensional echocardiography facilitates direct visualization of cardiac structures and adjacent vital organs, percutaneous pericardiocentesis can be performed with minimal risk. Since its inception in 1979 (19 years ago), the echocardiographically guided pericardiocentesis technique has continued to evolve. Important procedural adaptations and modifications that optimize safety, simplicity, and patient comfort and minimize the recurrence of effusion have been defined and incorporated. This technique has been proved to be safe and effective. A detailed step-by-step description of the procedure and the necessary precautions to optimize success and safety is presented herein.

Entities:  

Mesh:

Year:  1998        PMID: 9663193     DOI: 10.1016/S0025-6196(11)64888-X

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  35 in total

1.  Discrimination between pericardial disease and myocardial disease using tissue Doppler imaging in a patient with right-sided heart failure and multiple myeloma.

Authors:  K G van Houwelingen; J J Bax; J W Jukema; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2003-02       Impact factor: 2.357

2.  Post-Myocardial Infarction Pericarditis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

3.  Perflutren microspheres for contrast echocardiography in a bloody pericardiocentesis.

Authors:  José E Escabí-Mendoza; Jorge D Martínez-Díaz; Eric D Avilés-Rivera
Journal:  Tex Heart Inst J       Date:  2006

Review 4.  Echocardiographic guidance for diagnostic and therapeutic percutaneous procedures.

Authors:  Cam Tu Nguyen; Eunice Lee; Huai Luo; Robert J Siegel
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

5.  Contrast medium echocardiography-assisted pericardiocentesis of loculated pericardial fluid.

Authors:  K G van Houwelingen; J J Bax; J W Jukema; E E van der Wall
Journal:  Neth Heart J       Date:  2002-08       Impact factor: 2.380

Review 6.  Pediatric emergency medicine point-of-care ultrasound: summary of the evidence.

Authors:  Jennifer R Marin; Alyssa M Abo; Alexander C Arroyo; Stephanie J Doniger; Jason W Fischer; Rachel Rempell; Brandi Gary; James F Holmes; David O Kessler; Samuel H F Lam; Marla C Levine; Jason A Levy; Alice Murray; Lorraine Ng; Vicki E Noble; Daniela Ramirez-Schrempp; David C Riley; Turandot Saul; Vaishali Shah; Adam B Sivitz; Ee Tein Tay; David Teng; Lindsey Chaudoin; James W Tsung; Rebecca L Vieira; Yaffa M Vitberg; Resa E Lewiss
Journal:  Crit Ultrasound J       Date:  2016-11-03

7.  Pericardial Diseases.

Authors:  Samer S. Kabbani; Martin M. LeWinter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

Review 8.  Interventional Pericardiology.

Authors:  Mandeep Bhargava; Oussama M Wazni; Walid I Saliba
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

9.  Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History.

Authors:  Kye Hun Kim; William R Miranda; Larry J Sinak; Faisal F Syed; Rowlens M Melduni; Raul E Espinosa; Garvan C Kane; Jae K Oh
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-05

10.  Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade.

Authors:  Witold Zbyszek Tomkowski; Joanna Wiśniewska; Monika Szturmowicz; Paweł Kuca; Janusz Burakowski; Jarosław Kober; Anna Fijałkowska
Journal:  Support Care Cancer       Date:  2003-09-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.